The Personal Touch: Ortho Implants Challenger Corin Creates Its Own Value Pathway

Mid-size orthopedic implants group Corin is back in the public eye after its recent purchase by a Permira-funded group. Now ready to embark on the next chapter of its development globally, it has a clear growth plan and a firm strategic line on both what it will and will not do as a business.

Corin Orthopaedics Holdings was no slouch in the press and PR department, especially in the early years of the new millennium, when its financial and hip and knee product news churn was often hard to keep up with. That changed in late 2012, when a consortium of private equity investors, based mainly in Italy, set up the 2IL Orthopaedics vehicle to buy Corin for £30.5 million ($48 million). Corin then largely went under the radar and out of public view.

There was the odd news feed about big M&A (Tornier, among others), however, and the group kept growing its revenues...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Innovation

More from In Vivo